Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography.

Small, William; Mehard, W B; Langmo, L. S.; Dagher, Azar P.; Fishman, Elliot K.; Heiken, Jay P.; Bernardino, Michael E.

doi:10.2214/ajr.161.2.8333369

Cited by 64 publications

(18 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These Survival data were gathered in an era of less sophisticated hepatic imaging prior to surgery. Thus, the patient survival statistics reported to date have not been correlated with newer imaging techniques which are able to detect smaller metastatic deposits and thus exclude some patients from unnecessary surgery [20]. Several studies have compared various imaging techniques for the detection of focal hepatic masses.…”

Section: Discussionmentioning

confidence: 99%

Does CTAP prior to hepatic resection improve patient survival rates?

et al. 1994

View full text Add to dashboard Cite

The purpose of our study was to compare survival rates of colon carcinoma patients who had undergone attempted curative hepatic resection based on liver staging by computed tomographic angiography (CTA) or portography (CTAP) with previously reported survival rates of patients who underwent similar surgery without preoperative CTAP evaluations. A total of 404 CTAP studies performed at three institutions were reviewed. Of this group, 197 had colon carcinoma. Sixty-nine of the colon patients went to surgery. Actuarial adjusted yearly survival rates were calculated for the prior CTAP colon group and compared to historical controls. The control survival data were taken from reports published prior to the CTAP era. Our study demonstrated no difference in the 1-year survival data between the groups. However, the CTAP patients had greater survival in years 2-4. This greater survival may be multifactorial but in part due to better surgical selection caused by CTAP.

show abstract

Section: Discussionmentioning

confidence: 99%

Does CTAP prior to hepatic resection improve patient survival rates?

et al. 1994

View full text Add to dashboard Cite

show abstract

“…The hepatic arterial catheter for CTA was placed in the celiac (five patients), common hepatic (19), or replaced right hepatic (two) artery, and then the superior mesenteric arterial catheter for CTAP was positioned. Less than 20 mL of 60-70% nonionic contrast agent was typically used to confirm the catheter tip position.…”

Section: Imaging Techniquementioning

confidence: 99%

Methodological assessment of combined spiral CT angiography and CT arterial portography

et al. 1997

View full text Add to dashboard Cite

show abstract

“…Hepatic metastasis complicates 20-30% of colorectal cancer cases [1,2], Recent advances in imaging tech niques facilitate accurate identification of the number, size and location of hepatic metastasis for planning surgi cal procedures [3,4], During the last decade, numerous reports have confirmed that 25 to 40% of patients treated by hepatic resection have a 5-year survival [5][6][7], How ever, despite a significant improvement over the results of unresectable hepatic metastasis in recent years, 5-year survivors are still rare [8,9], There are two types of hepatic metastasis: synchronous hepatic metastasis, which is diagnosed within 6 months after the diagnosis of colorectal carcinoma as defined by Attiveh et al [10], and metachronous hepatic metastasis, manifesting evident hepatic metastasis during the follow up periods after colorectal resection. In the latter type of metastasis, despite the fact that no visible metastasis is recognized at the time of colorectal surgery, it is possible that micrometastasis exists in the liver.…”

Section: Introductionmentioning

confidence: 99%

Differences in Tumor Growth Measured by Carcinoembryonic Antigen Doubling Time between Synchronous and Metachronous Hepatic Colorectal Metastases

Ouchi¹,

Sugawara²,

Ono³

et al. 1997

Dig Surg

View full text Add to dashboard Cite

The operative results and carcinoembryonic antigen (CEA) doubling times of patients with synchronous hepatic metastasis (group A) and metachronous hepatic metastasis (group B) from colorectal carcinoma were compared. Better survival was exhibited in group A and group B patients who underwent hepatic resection than in those who did not undergo hepatic resection. Group B patients with resectable metastasis also exhibited longer survival times compared to patients with similar CEA doubling times and without hepatic resection. Among the patients who did not undergo hepatic resection, group B showed better survival times than group A after colorectal resection, and the CEA doubling time obtained from 6 patients in group B (83 ± 22 days) was significantly longer than that obtained from 10 patients in group A (55 ± 19 days). The CEA doubling time correlated well with the survival time in unresectable group B patients. The better survival of group B patients may be due not only to the delay in detection of hepatic metastasis but also to the slower growth kinetics of the tumor per se, which were suggested by a longer CEA doubling time.

show abstract

Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography.

Cited by 64 publications

References 5 publications

Does CTAP prior to hepatic resection improve patient survival rates?

Does CTAP prior to hepatic resection improve patient survival rates?

Methodological assessment of combined spiral CT angiography and CT arterial portography

Differences in Tumor Growth Measured by Carcinoembryonic Antigen Doubling Time between Synchronous and Metachronous Hepatic Colorectal Metastases

Contact Info

Product

Resources

About